Journal Articles

Raynaud K, Seguy D, Rogosnitzky M, Saulnier F, Pruvot FR, Zerbib Ph. Conservative management of severe caustic injuries during acute phase leads to superior long-term nutritional and quality of life (QoL) outcome Langebecks Arch Surg, 2016 ;401(1):81-7. [PubMed]
Rogosnitzky M. and Branch S. Gadolinium-Based Contrast Agent Toxicity- A Review of Known and Proposed Mechanisms BioMetals, 2016 ;29(3), 365-376. [PubMed] [Full Article]
Rogosnitzky Moshe, Isakov Itzhak, Wlassoff Wjatschesslaw, Ingram April, and Barishak Y. Robert. Ocular Applications of Dipyridamole: A Review of Indications and Routes of Administration Journal of Ocular Pharmacology and Therapeutics, 2015 ;32(2):83-9. [PubMed] [Full Article]
Bauters A, Rogosnitzky M, Hachulla E, Copin MC, Saudemont A, Zerbib P Elevated Plasma Fibrinogen in Clinically Asymptomatic Unicentric Castleman's Disease: A Case Report. J Clin Exp Hematop, 2014 ;54(1):85-8. [PubMed] [Full Article]
Zerbib P, Vinet A, Rogosnitzky M, Truant S, Chambon JP, Pruvot FR. Gastrocele Complicates the Course of Non-operated Severe Caustic Injuries: Operative Strategies. World J. Surg, 2014 ;38(5): 1233-7. [PubMed]
Dalgleish A, Featherstone P, Vlassov V, Rogosnitzky M. Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature. Invest New Drugs, 2014 [PubMed]
Carlock BH, Bienstock CA, Rogosnitzky M. Pterygium: nonsurgical treatment using topical dipyrdiamole - a case report. Case Rep Ophthalmol, 2014 ;5(1):98-103. [PubMed] [Full Article]
A Bauters, DJ Holt, P Zerbib, M Rogosnitzky. Gallium nitrate induces fibrinogen flocculation: an explanation for its hemostatic effect? Biometals, 2013 [PubMed]
Lebas A, Rogosnitzky M, Chater C, Colombel JF, Nachury M, Cortot A, and Zerbib Ph. Efficacy of sacral nerve stimulation for poor functional results of J-Pouch ileoanal anastomosis: a pilot study. Techniques in Coloproctology, 2013 [PubMed]
Ph Zerbib, R Caiazzo, G Piessen, M Rogosnitzky, C Séquier, D Koriche, S Truant, E Boleslawski, J-P Chambon, F Pruvot. Outcome in porcine acellular dermal matrix reinforcement of infected abdominal wall defects – a prospective study. 2013 [PubMed]
Rogosnitzky M, Danks R, Holt D. Intravenous Immunoglobulin for the treatment of Crohn's disease (review). Autoimmunity Reviews, 2012 [PubMed] [Full Article]
Rogosnitzky M, Danks R, Kardash E. Therapeutic Potential of Tranilast, an Anti-allergy Drug, in Proliferative Disorders (review). Anticancer Res, 2012 ;32(7): 2471- 2478. [PubMed] [Full Article]
Rogosnitzky M, Finegold MJ, McLauglin PJ, Zagon IS. Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment. Invest New Drugs, 2012 [PubMed]
Rogosnitzky M, Danks R. The therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions (review). Pharmacological Reports, 2011 ;63, 337-347. [PubMed] [Full Article]
Goodley PH, Rogosnitzky M. The Effect of Gallium Nitrate on Arresting Blood Flow from a Wound. Case Reports in Medicine, 2011 ;Article ID 819710. [PubMed] [Full Article]
Barken I, Geller J, Rogosnitzky M. Prophylactic noscapine inhibits prostate cancer in a mouse model. Anticancer Res, 2010 ;30(2):399-401. [PubMed] [Full Article]
Rogosnitzky M, Danks R Validation of blood testing for K-ras mutations in colorectal and pancreatic cancer. A short review. Anticancer Res, 2010 ;30(7):2943-2947. [PubMed] [Full Article]
PJ McLaughlin, M Rogosnitzky and IS Zagon. Inhibition of DNA synthesis in mouse epidermis by topical imiquimod is dependent on opioid receptors. Exp Biol Med (Maywood), 2010 ;235(11): 1292-99. [PubMed]
Zagon I, Donahue RN, Rogosnitzky M, McLaughlin PJ. Imiquimod Upregulates the Opioid Growth Factor Receptor to Inhibit Cell Proliferation Independent of Immune Function. Exp Biol Med (Maywood), 2008 ;233: 968-979. [PubMed]
Barken I, Geller J, Rogosnitzky M. Noscapine inhibits human prostate cancer progression and metastasis in a mouse model. Anticancer Res, 2008 ;28(6A):3701-3704. [PubMed] [Full Article]
Smith JP, Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS. Low-dose naltrexone therapy improves active Crohn's disease. Am J Gastroenterol, 2007 ;102(4):820-8. [PubMed]
Hurst WJ, M Rogosnitzky, PJ McLaughlin, and IS Zagon. The stability of opioid growth factor ([Met5]-enkephalin) in solution using HPLC and photodiode array detection. J. Liquid Chromatography & Related Technologies, 2006 ;29:1-7. [Journal]

Book Chapters

Moshe Rogosnitzky and Rachel Danks Testosterone for the Treatment of Mammary and Prostate Cancers: Historical Perspectives and New Directions Advances in Cancer Management, 2012 ;ISBN: 978-953-307-870-0.


Moshe Rogosnitzky, Carol A Bienstock, Yitzchak Issakov, Aaron Frenkel Topical Dipyridamole for Treatment of Pterygium and Associated Dry Eye Symptoms: Analysis of UserReported Outcomes ISVER Conference Proceedings, 2016 [PDF]
T. Armaghany, G. Vahdati, S. Broline, R. Goshen, M. Rogosnitzky, E. Delpassand Dramatic response with peptide receptor radionuclide therapy with 177Lu-DOTATATE and capecitabine in the treatment of metastatic thymic carcinoma Journal of Nuclear Medicine, 2015 ;56 no. Supplement 2 2A-30. [Journal]
Raynaud, Kevin, Benoit Voisin, Dine Koriche, Moshe Rogosnitzky, Fabienne Saulnier, François-René Pruvot, Jean-Pierre Chambon, and Philippe Zerbib. Sa1953 Severe Gastric Caustic Injuries (SGCI)-Conservative Management During Acute Phase Leads to Superior Long-Term Quality of Life (QOL) and Nutritional Outcome. Gastroenterology, ;144, no. 5 (2013): S-343.